USFDA concludes audit at contract manufacturing facility of Jubilant Pharmova’s step down arm

18 Jun 2024 Evaluate

United States Food and Drug Administration (USFDA) has concluded audit at Jubilant Pharmova’s wholly-owned subsidiary -- Jubilant HollisterStier’s subsidiary -- Jubilant HollisterStier General Partnership’s (JHSGP) contract manufacturing facility located in Montreal, Canada. The USFDA has issued 15 observations pursuant to the completion of audit. JHSGP will submit an action plan on the observations.

Jubilant Pharmova (formerly Jubilant Life Sciences) is a company engaged in pharmaceuticals, contract research and development services and proprietary novel drugs businesses.


Jubilant Pharmova Share Price

916.45 -2.70 (-0.29%)
15-Apr-2025 12:51 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1707.70
Dr. Reddys Lab 1146.30
Cipla 1468.20
Lupin 2000.20
Zydus Lifesciences 876.35
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...